Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Pharmacovigilance and Drug Safety Software Market: By Functionality: Adverse Event Reporting Software, Drug Safety Audits Software, Others; By Mode of Delivery; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments
Global Pharmacovigilance and Drug Safety Software Market Outlook
The global pharmacovigilance and drug safety software market is anticipated to grow at a CAGR of 5.8% over the forecast period 2021-2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
After licensing, pharmacovigilance is the profession of tracking the impacts of medical drugs. This is performed in particular to recognize and examine the prior unfavourable responses of unannounced pharmaceutical drugs.
The global market for pharmacovigilance and drug safety software is expected to accelerate due to the increasing incidences of ADR or adverse drug reaction and the rise of several outsourcing businesses adopting interconnected software services. With an increased demand for different drugs and medicines worldwide and the ongoing attempts to produce secure medicines and the growing pressure on numerous biotech and pharmaceutical companies, the market is anticipated to experience significant development in the years to come.
Properties and Applications
The pharmacovigilance and drug safety software market can be divided on the basis of segments like functionality, mode of delivery, and end-use.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be categorised on the basis of its functionality as drug safety audits software, adverse event reporting software, issue tracking software, and fully integrated software. The industry can be divided based on its mode of delivery as on-premise delivery and on-demand/ cloud-based (SaaS) delivery. The industry can be broadly categorised based on its end-use into:
- Pharma and Biotech Companies
- Contract Research Organizations (CROs)
- Business Process Outsourcing (BPO) Firms
- Others
The EMR report looks into the regional markets of pharmacovigilance and drug safety software like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The adoption of pharmacovigilance software in the market has become simpler for players with readily available information and the decreased use of obsolete information. The critical use of pharmacovigilance and drug safety is projected to boost the global market for multiple clinical research. As a consequence of particular drug consumption, the increase in patient safety problems, and the surge in adverse side effects may increase the global drug safety software and pharmacovigilance market. This market growth could also be mainly be correlated with the accessibility of clinical trial programs and reductions in medical spending.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global pharmacovigilance and drug safety software industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- ArisGlobal
- Ennov Solutions Inc.
- EXTEDO GmbH
- Oracle Corporation (NYSE: ORCL)
- Sparta Systems, Inc.
- United BioSource Corporation
- AB Cube
- UMBRA Global LLC
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Functionality, Mode of Delivery, End Use, Region |
| Breakup by Functionality | Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software |
| Breakup by Mode of Delivery | On-Premise Delivery, On-Demand/ Cloud-Based (SaaS) Delivery |
| Breakup by End Use | Pharma and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | ArisGlobal, Ennov Solutions Inc., EXTEDO GmbH, Oracle Corporation, Sparta Systems, Inc., United BioSource Corporation, AB Cube, UMBRA Global LLC |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Pharmacovigilance and Drug Safety Software Market Analysis
8.1 Key Industry Highlights
8.2 Global Pharmacovigilance and Drug Safety Software Historical Market (2016-2020)
8.3 Global Pharmacovigilance and Drug Safety Software Market Forecast (2021-2026)
8.4 Global Pharmacovigilance and Drug Safety Software Market by Functionality
8.4.1 Adverse Event Reporting Software
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Drug Safety Audits Software
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Issue Tracking Software
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Fully Integrated Software
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2016-2020)
8.4.4.3 Forecast Trend (2021-2026)
8.5 Global Pharmacovigilance and Drug Safety Software Market by Mode of Delivery
8.5.1 On-Premises Delivery
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 On-Demand/Cloud Based (SaaS) Delivery
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.6 Global Pharmacovigilance and Drug Safety Software Market by End Use
8.6.1 Pharma and Biotech Companies
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Contract Research Organizations (CROs)
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Business Process Outsourcing (BPO) Firms
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Others
8.7 Global Pharmacovigilance and Drug Safety Software Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Arisglobal LLC
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Ennov Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 EXTEDO GmbH
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Oracle Corporation
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Sparta Systems Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 United BioSource LLC
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Others
12 Industry Events and Developments
List of Figures and Tables
1. Global Pharmacovigilance and Drug Safety Software Market: Key Industry Highlights, 2016 and 2026
2. Global Pharmacovigilance and Drug Safety Software Historical Market: Breakup by Functionality (USD Million), 2016-2020
3. Global Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Functionality (USD Million), 2021-2026
4. Global Pharmacovigilance and Drug Safety Software Historical Market: Breakup by Mode of Delivery (USD Million), 2016-2020
5. Global Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Mode of Delivery (USD Million), 2021-2026
6. Global Pharmacovigilance and Drug Safety Software Historical Market: Breakup by End Use (USD Million), 2016-2020
7. Global Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by End Use (USD Million), 2021-2026
8. Global Pharmacovigilance and Drug Safety Software Historical Market: Breakup by Region (USD Million), 2016-2020
9. Global Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Region (USD Million), 2021-2026
10. North America Pharmacovigilance and Drug Safety Software Historical Market: Breakup by Country (USD Million), 2016-2020
11. North America Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Country (USD Million), 2021-2026
12. Europe Pharmacovigilance and Drug Safety Software Historical Market: Breakup by Country (USD Million), 2016-2020
13. Europe Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Country (USD Million), 2021-2026
14. Asia Pacific Pharmacovigilance and Drug Safety Software Historical Market: Breakup by Country (USD Million), 2016-2020
15. Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Country (USD Million), 2021-2026
16. Latin America Pharmacovigilance and Drug Safety Software Historical Market: Breakup by Country (USD Million), 2016-2020
17. Latin America Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Country (USD Million), 2021-2026
18. Middle East and Africa Pharmacovigilance and Drug Safety Software Historical Market: Breakup by Country (USD Million), 2016-2020
19. Middle East and Africa Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Country (USD Million), 2021-2026
20. Global Pharmacovigilance and Drug Safety Software Market Structure
Key Questions Answered in the Report
The global pharmacovigilance and drug safety software market is estimated to witness a healthy growth, expanding at a CAGR of 5.8% in the forecast period of 2021-2026.
The major drivers of the market include the increasing incidences of ADR (adverse drug reaction) and the growing adoption of interconnected software services by several outsourcing businesses.
The increasing demand for different drugs and medicines worldwide and ongoing attempts to improve access to safe and effective drugs are expected to be the key trends guiding the growth of the industry.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Drug safety audits software, adverse event reporting software, issue tracking software, and fully integrated software are the major functionalities of the product.
On-premise delivery and on-demand/ cloud-based (SaaS) delivery are the different delivery modes of the product in the market.
Pharma and biotech companies, contract research organisations (CROs), and business process outsourcing (BPO) firms, among others are the significant end uses of the product in the market.
The major players in the industry are ArisGlobal, Ennov Solutions Inc., EXTEDO GmbH, Oracle Corporation, Sparta Systems, Inc., United BioSource Corporation, AB Cube, and UMBRA Global LLC, among others.
Analyst Review
The global pharmacovigilance and drug safety software market is being driven by the increasing incidences of ADR or adverse drug reaction and the rise of several outsourcing businesses adopting interconnected software services. Aided by the increasing focus on patient safety and growing efforts to provide safe and effective drugs, the market is anticipated to grow at a CAGR of 5.8% in the forecast period of 2021-2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on functionality, the market is divided into drug safety audits software, adverse event reporting software, issue tracking software, and fully integrated software. On the basis of mode of delivery, the market is segmented into on-premise delivery and on-demand/ cloud-based (SaaS) delivery. Based on end use, the market is divided into pharma and biotech companies, contract research organisations (CROs), and business process outsourcing (BPO) firms, among others. The major regional markets for pharmacovigilance and drug safety software are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include ArisGlobal, Ennov Solutions Inc., EXTEDO GmbH, Oracle Corporation, Sparta Systems, Inc., United BioSource Corporation, AB Cube, and UMBRA Global LLC, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global venipuncture procedure analysis market attained a value of about USD 864.2 million in 2020, driven by the presence of various blood diseases. Aided by the advancements in venipuncture proce...
The global healthcare analytics market attained a value of about USD 13.6 billion in 2020, driven by the rise in big data and healthcare sectors. Aided by the growing popularity of descriptive analyti...
The global hospital EMR system market attained a value of USD 14.2 billion in 2020, driven by the growing R&D activities and rapid technological advancements. Aided by the growing hospitalisation rate...
The global medical coding market stood at a value of around USD 15.3 billion in 2020. The market is further expected to grow at a CAGR of 10.9% in the forecast period of 2021-2026 to attain a value of...
The global ehealth market attained a value of nearly USD 206 billion in 2020, driven by the growing popularity of telemedicine. Aided by the development of safe, efficient, and cost-effective electron...
NEWSLETTER